Login to Your Account



Search

Search results

Pharma: clinic roundup

Pfizer Inc. , of New York, reported that detailed results of the Community-Acquired Pneumonia Immunization Trial in Adults, or CAPiTA, which enrolled approximately 85,000 subjects, demonstrated that Prevenar 13 (pneumococcal polysaccharide conjugat ...

BioWorld Today - Staff - 2014-03-12 23:00 - 0 comments - 0 attachments

Clinic roundup

Cytonet GmbH & Co. KG , of Weinheim, Germany, said interim data on its liver cell therapy treatment presented at the Society for Inherited Metabolic Disorders meeting in Pacific Grove, Calif., showed that pediatric patients with urea cycle disord ...

BioWorld Today - Staff - 2014-03-11 23:00 - 0 comments - 0 attachments

Clinic roundup

Betagenon AB and Baltic Bio AB , both of Stockholm, said phase I studies began with O304, an orally available AMPK activator. (BioWorld-Today-2014-03-11) ...

BioWorld Today - Staff - 2014-03-10 23:00 - 0 comments - 0 attachments

Clinic roundup

Northwest Biotherapeutics Inc. , of Bethesda, Md., said the data safety monitoring board has made an unblinded review of the safety data for the company’s ongoing international phase III glioblastoma trial with DCVax-L, using activated dendritic ce ...

BioWorld Today - Staff - 2014-03-09 23:00 - 0 comments - 0 attachments

Clinic Roundup

Esperion Therapeutics Inc. , of Plymouth, Mich., reported in conjunction with its 2013 year-end results that it plans this month to initiate the ETC-1002-009 phase IIb study of parallel doses of lead compound, ETC-1002, over 12 weeks added to stati ...

BioWorld Today - Staff - 2014-03-07 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim GmbH , of Ingelheim, Germany, reported results from the phase III STARTVerso 4 trial in patients co-infected with hepatitis C virus (HCV) and HIV, showing that HCV cure 12 weeks (SVR12) after the conclusion of treatment was ach ...

BioWorld Today - Staff - 2014-03-07 00:00 - 0 comments - 0 attachments

Clinic roundup

Ico Therapeutics Inc. , of Vancouver, British Columbia, disclosed the final, eight-month patient visit in the phase II iDEAL study. The investigator-sponsored study is evaluating the efficacy and safety of ICO-007 after repeated injections in pat ...

BioWorld Today - Staff - 2014-03-06 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Roche AG , of Basel, Switzerland, presented new data from the LUTE/VERSE phase IIb studies investigating lebrikizumab in patients with severe uncontrolled asthma. The data showed that asthma attacks were reduced by 60 percent in lebrikizumab-trea ...

BioWorld Today - Staff - 2014-03-06 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Janssen Pharmaceutica NV , of Beerse, Belgium, part of Johnson & Johnson, reported results from the PROSIPAL (Prevention of Relapse With Oral Antipsychotics Versus Injectable Paliperidone Palmitate) study at the European Congress of Psychiatry ...

BioWorld Today - Staff - 2014-03-05 00:00 - 0 comments - 0 attachments

Clinic roundup

Boston Therapeutics Inc. , of Manchester, N.H., said it received institutional review board approval to start a phase II study of BTI-320 (formerly PAZ320), a nonsystemic chewable complex carbohydrate-based compound, in the U.S. (BioWorld-To ...

BioWorld Today - Staff - 2014-03-05 00:00 - 0 comments - 0 attachments